APTIMA HPV assay performance in women with atypical squamous cells of undetermined significance cytology results.
about
Human papillomavirus testing versus repeat cytology for triage of minor cytological cervical lesionsClinical significance of human papillomavirus genotypingComparison of human papillomavirus detection by Aptima HPV and cobas HPV tests in a population of women referred for colposcopy following detection of atypical squamous cells of undetermined significance by Pap cytology.The Aptima HPV assay fulfills the cross-sectional clinical and reproducibility criteria of international guidelines for human papillomavirus test requirements for cervical screeningDisagreement between human papillomavirus assays: an unexpected challenge for the choice of an assay in primary cervical screening.Comparison of commercial hybridization and automated transcription-mediated amplification modalities for detection of high-risk human papillomavirus nucleic acid.Effect of preanalytical processing of ThinPrep specimens on detection of high-risk human papillomavirus by the Aptima HPV assay.FHACT: the FISH-based HPV-associated cancer test that detects nonrandom gain at four genomic loci as biomarkers of disease progression.Using novel biomarkers to triage young adult women with minor cervical lesions: a cost-effectiveness analysis.Referral population studies underestimate differences between human papillomavirus assays in primary cervical screening.Expression of HPV-related biomarkers and grade of cervical intraepithelial lesion at treatment.Secondary Prevention of Cervical Cancer: ASCO Resource-Stratified Clinical Practice Guideline.Performance of the cobas HPV Test for the Triage of Atypical Squamous Cells of Undetermined Significance Cytology in Cervical Specimens Collected in SurePath.E6/E7 proteins are potential markers for the screening and diagnosis of cervical pre-cancerous lesions and cervical cancer in a Chinese population.Feasibility study of a human papillomavirus E6 and E7 oncoprotein test for the diagnosis of cervical precancer and cancer.Separate analysis of human papillomavirus E6 and E7 messenger RNAs to predict cervical neoplasia progression.
P2860
Q24198236-C0C4B71A-3CF8-4A21-A99C-DC31B3D9C067Q26771981-9E4445AB-77DC-42D5-9354-324C86898AE1Q35193205-9C6A57F6-6692-4693-869A-F21F60A46B7FQ37470374-F56CDEE3-B3DB-4ADA-99B7-9CBE1D57E811Q37496183-96E12CE1-A381-46AD-85DC-4DB2BB093F0BQ37546570-5C1CE542-6F5F-46CB-98E6-E247C9B1E5CCQ37713738-9DBBA8E3-6F8F-4859-AC08-A503B33C433CQ38259453-E95BEF80-7B42-48F1-99D4-41BBEFEF3814Q39708564-223559AE-F120-4AD8-8AFA-48C0320621B7Q40043990-520A18C2-F723-4E1E-8849-7BDCDF32ACACQ43821078-EE2407B4-A17A-4933-BBF3-D1EBA171C407Q43924111-C07C8615-B149-4C18-8F95-56302E81E5BAQ46041958-3E76A880-B89A-48D1-B039-8475831B42D5Q47113153-B2F38894-6F28-49A2-9D2F-8734CCBFA0E3Q48263482-F6307E25-935E-4605-B7F4-35891A3F52B3Q54269409-C1B8E71D-9A32-4093-9C6D-E46E654852DF
P2860
APTIMA HPV assay performance in women with atypical squamous cells of undetermined significance cytology results.
description
2012 nî lūn-bûn
@nan
2012 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
APTIMA HPV assay performance i ...... significance cytology results.
@ast
APTIMA HPV assay performance i ...... significance cytology results.
@en
type
label
APTIMA HPV assay performance i ...... significance cytology results.
@ast
APTIMA HPV assay performance i ...... significance cytology results.
@en
prefLabel
APTIMA HPV assay performance i ...... significance cytology results.
@ast
APTIMA HPV assay performance i ...... significance cytology results.
@en
P2093
P1476
APTIMA HPV assay performance i ...... significance cytology results.
@en
P2093
Cristina Giachetti
Damon Getman
Jack Cuzick
Janel Dockter
Jennifer L Reid
Mark H Stoler
Thomas C Wright
P304
P356
10.1016/J.AJOG.2012.12.003
P407
P577
2012-12-05T00:00:00Z